BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 23382999)

  • 1. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
    Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
    PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.
    Du H; Guo L; Wu X; Sosunov AA; McKhann GM; Chen JX; Yan SS
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2517-27. PubMed ID: 23507145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.
    Du H; Guo L; Fang F; Chen D; Sosunov AA; McKhann GM; Yan Y; Wang C; Zhang H; Molkentin JD; Gunn-Moore FJ; Vonsattel JP; Arancio O; Chen JX; Yan SD
    Nat Med; 2008 Oct; 14(10):1097-105. PubMed ID: 18806802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.
    Du H; Yan SS
    Biochim Biophys Acta; 2010 Jan; 1802(1):198-204. PubMed ID: 19616093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model.
    Du H; Guo L; Zhang W; Rydzewska M; Yan S
    Neurobiol Aging; 2011 Mar; 32(3):398-406. PubMed ID: 19362755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
    Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH
    Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.
    Du H; Guo L; Yan S; Sosunov AA; McKhann GM; Yan SS
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18670-5. PubMed ID: 20937894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
    Calkins MJ; Reddy PH
    Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
    Hausenloy DJ; Lim SY; Ong SG; Davidson SM; Yellon DM
    Cardiovasc Res; 2010 Oct; 88(1):67-74. PubMed ID: 20400621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.
    Park I; Londhe AM; Lim JW; Park BG; Jung SY; Lee JY; Lim SM; No KT; Lee J; Pae AN
    J Comput Aided Mol Des; 2017 Oct; 31(10):929-941. PubMed ID: 28913661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease.
    Gauba E; Chen H; Guo L; Du H
    Neurobiol Dis; 2019 Jan; 121():138-147. PubMed ID: 30266287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.
    Rao VK; Carlson EA; Yan SS
    Biochim Biophys Acta; 2014 Aug; 1842(8):1267-72. PubMed ID: 24055979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal degeneration is mediated by the mitochondrial permeability transition pore.
    Barrientos SA; Martinez NW; Yoo S; Jara JS; Zamorano S; Hetz C; Twiss JL; Alvarez J; Court FA
    J Neurosci; 2011 Jan; 31(3):966-78. PubMed ID: 21248121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophilin D-mediated Mitochondrial Permeability Transition Regulates Mitochondrial Function.
    Zhou S; Yu Q; Zhang L; Jiang Z
    Curr Pharm Des; 2023; 29(8):620-629. PubMed ID: 36915987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro study of interaction of 17β-hydroxysteroid dehydrogenase type 10 and cyclophilin D and its potential implications for Alzheimer's disease.
    Hemmerová E; Špringer T; Krištofiková Z; Homola J
    Sci Rep; 2019 Nov; 9(1):16700. PubMed ID: 31723183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane.
    Zhang L; Trushin S; Christensen TA; Tripathi U; Hong C; Geroux RE; Howell KG; Poduslo JF; Trushina E
    Neurobiol Dis; 2018 Jun; 114():1-16. PubMed ID: 29477640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore.
    Nguyen TT; Stevens MV; Kohr M; Steenbergen C; Sack MN; Murphy E
    J Biol Chem; 2011 Nov; 286(46):40184-92. PubMed ID: 21930693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
    Samanta S; Akhter F; Roy A; Chen D; Turner B; Wang Y; Clemente N; Wang C; Swerdlow RH; Battaile KP; Lovell S; Yan SF; Yan SS
    Brain; 2024 May; 147(5):1710-1725. PubMed ID: 38146639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CypD-mPTP axis regulates mitochondrial functions contributing to osteogenic dysfunction of MC3T3-E1 cells in inflammation.
    Gan X; Zhang L; Liu B; Zhu Z; He Y; Chen J; Zhu J; Yu H
    J Physiol Biochem; 2018 Aug; 74(3):395-402. PubMed ID: 29679227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.